Program Overview

Introduction to the Biomedical Engineering Program

The University of Missouri Board of Curators has unanimously approved the new bachelor's degree program in biomedical engineering at Missouri S&T. This program aims to train the engineering workforce of the future at the intersection of engineering and medicine.

Program Overview

The biomedical engineering program will be housed in the Department of Chemical and Biochemical Engineering at Missouri S&T. The program will provide students with a top-tier education, preparing them for a variety of biomedical-related issues, including pharmaceutical research, medical device development, and tissue engineering.

Career Paths

Potential career paths for graduates of the biomedical engineering program include:

• Pharmaceutical research
• Developing medical devices and prosthetics
• Tissue engineering
• Researching potential organ repair and replacement methods
• Earning advanced degrees in related areas, such as medicine

Faculty Expertise

The program will be led by renowned faculty members, including:

• Dr. Hu Yang, the Linda and Bipin Doshi Chair of Chemical and Biochemical Engineering
• Dr. Delbert Day, Curators' Distinguished Professor emeritus of materials science and engineering
• Dr. Richard Brow, Curators' Distinguished Professor of ceramic engineering and special assistant to the provost for academics
• Dr. Mark Towler, Doshi Professor of Chemical and Biochemical Engineering
• Dr. Anthony Convertine, Roberta and G. Robert Couch Assistant Professor of Materials Science and Engineering

Research Areas

Faculty members are currently researching various areas, including:

• Nanotechnology for glaucoma treatment
• Radioactive glass microspheres for cancer treatment
• Glass development for biomedical applications
• Diagnostic devices for bone fracture risk analysis
• Nanomaterials for 3D-printing human tissue
• Wound care treatments
• Diagnostic instruments for doctors and patients

Industry Support

The program has received support from various organizations, including Pfizer, Curium Pharma, Emerson, and DeNovix Inc. These organizations recognize the importance of developing a strong talent pipeline to support growth and innovation in the biopharmaceutical and biomedical sectors.

Program Launch

The university aims to admit students into the new program starting in fall 2024, pending approval from the Missouri Coordinating Board for Higher Education (CBHE).

Conclusion

The new biomedical engineering program at Missouri S&T is poised to provide students with a comprehensive education, preparing them for exciting career opportunities in the biomedical field. With its strong faculty expertise and industry support, the program is expected to make significant contributions to the field of biomedical engineering.